Dan Barouch
Dan Barouch
Harvard Medical School; Beth Israel Deaconess Medical Center
Verified email at - Homepage
Cited by
Cited by
Phenotypic analysis of antigen-specific T lymphocytes
JD Altman, PAH Moss, PJR Goulder, DH Barouch, ...
Science 274 (5284), 94-96, 1996
An immunogenic personal neoantigen vaccine for patients with melanoma
PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym, W Zhang, A Luoma, ...
Nature 547 (7662), 217-221, 2017
Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19
J Sadoff, G Gray, A Vandebosch, V Cárdenas, G Shukarev, B Grinsztejn, ...
New England Journal of Medicine 384 (23), 2187-2201, 2021
Interim results of a phase 1–2a trial of Ad26. COV2. S Covid-19 vaccine
J Sadoff, M Le Gars, G Shukarev, D Heerwegh, C Truyers, AM de Groot, ...
New England Journal of Medicine 384 (19), 1824-1835, 2021
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ...
Science 369 (6505), 806-811, 2020
Correlates of protection against SARS-CoV-2 in rhesus macaques
K McMahan, J Yu, NB Mercado, C Loos, LH Tostanoski, A Chandrashekar, ...
Nature 590 (7847), 630-634, 2021
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
DH Barouch, S Santra, JE Schmitz, MJ Kuroda, TM Fu, W Wagner, ...
Science 290 (5491), 486-492, 2000
Potently neutralizing and protective human antibodies against SARS-CoV-2
SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ...
Nature 584 (7821), 443-449, 2020
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ...
Nature 586 (7830), 583-588, 2020
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
A Chandrashekar, J Liu, AJ Martinot, K McMahan, NB Mercado, L Peter, ...
Science 369 (6505), 812-817, 2020
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
DH Barouch, J Kunstman, MJ Kuroda, JE Schmitz, S Santra, FW Peyerl, ...
Nature 415 (6869), 335-339, 2002
Animal models for COVID-19
C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ...
Nature 586 (7830), 509-515, 2020
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira, J Liu, ...
Nature 503 (7475), 224-228, 2013
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
JB Whitney, AL Hill, S Sanisetty, P Penaloza-MacMaster, J Liu, M Shetty, ...
Nature 512 (7512), 74-77, 2014
Adenovirus serotype 5 hexon mediates liver gene transfer
SN Waddington, JH McVey, D Bhella, AL Parker, K Barker, H Atoda, ...
Cell 132 (3), 397-409, 2008
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
AS Iyer, FK Jones, A Nodoushani, M Kelly, M Becker, D Slater, R Mills, ...
Science immunology 5 (52), eabe0367, 2020
Challenges in the development of an HIV-1 vaccine
DH Barouch
Nature 455 (7213), 613-619, 2008
Vaccine protection against Zika virus from Brazil
RA Larocca, P Abbink, JPS Peron, PM de A. Zanotto, MJ Iampietro, ...
Nature 536 (7617), 474-478, 2016
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts, A Nanda, MJE Havenga, P Abbink, DM Lynch, BA Ewald, ...
Nature 441 (7090), 239-243, 2006
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
P Abbink, AAC Lemckert, BA Ewald, DM Lynch, M Denholtz, S Smits, ...
Journal of virology 81 (9), 4654-4663, 2007
The system can't perform the operation now. Try again later.
Articles 1–20